414 related articles for article (PubMed ID: 6707908)
21. Improvement of reduced coronary vasodilatory response during reactive hyperemia by diltiazem.
Saito D; Ueeda M; Yamada N; Hina K; Watanabe H; Mima T; Hasui M; Kusachi S; Haraoka S; Tsuji T
Arzneimittelforschung; 1989 Apr; 39(4):440-5. PubMed ID: 2502126
[TBL] [Abstract][Full Text] [Related]
22. Differential effects of intravenous vs. intracoronary nifedipine on myocardial segment function in ischemic canine hearts.
Lamping KA; Gross GJ
J Pharmacol Exp Ther; 1984 Jan; 228(1):28-32. PubMed ID: 6694108
[TBL] [Abstract][Full Text] [Related]
23. Beneficial effects of the new calcium antagonist benidipine hydrochloride on myocardial dysfunction following coronary occlusion and reperfusion in anesthetized dogs.
Karasawa A; Kubo K; Shuto K; Oka T; Nakamizo N
Arzneimittelforschung; 1988 Nov; 38(11A):1717-21. PubMed ID: 3219147
[TBL] [Abstract][Full Text] [Related]
24. Effects of calcium entry blockers on coronary constriction and myocardial ischemia due to leukotriene D4.
Ezra D; Boyd LM; Goldstein RE; Feuerstein G
J Pharmacol Exp Ther; 1985 Apr; 233(1):229-34. PubMed ID: 3981457
[TBL] [Abstract][Full Text] [Related]
25. Effect of nifedipine and niludipine on myocardial pH in the ischemic canine heart.
Ichihara K; Sakai K; Abiko Y
Arch Int Pharmacodyn Ther; 1986 Mar; 280(1):58-73. PubMed ID: 3718082
[TBL] [Abstract][Full Text] [Related]
26. Effects of calcium channel blockers on the coronary circulation.
Cohn PF
Am J Hypertens; 1990 Dec; 3(12 Pt 2):299S-304S. PubMed ID: 2078316
[TBL] [Abstract][Full Text] [Related]
27. Comparative effects of calcium-channel blocking agents on left ventricular function during acute ischemia in dogs with and without congestive heart failure.
Urquhart J; Epstein SE; Patterson RE
Am J Cardiol; 1985 Jan; 55(3):10B-16B. PubMed ID: 3969856
[TBL] [Abstract][Full Text] [Related]
28. Effects of niludipine on regional myocardial blood flow and regional myocardial function in the dog with partial occlusion of the coronary artery.
Nomura H; Nagata K; Futamura Y; Mochizuki K; Hama Y; Sotobata I; Yasui S
Arzneimittelforschung; 1980; 30(8):1258-62. PubMed ID: 7192140
[TBL] [Abstract][Full Text] [Related]
29. Calcium-channel blocking agents.
Leonard RG; Talbert RL
Clin Pharm; 1982; 1(1):17-33. PubMed ID: 6764159
[TBL] [Abstract][Full Text] [Related]
30. Studies on mechanisms of diltiazem-induced protection of the ischemic myocardium: selective myocardial depressant action of diltiazem on an ischemic isolated blood-perfused canine papillary muscle preparation.
Ngai JH; Yabuuchi Y; Schwartz A; Millard RW
J Pharmacol Exp Ther; 1983 May; 225(2):462-9. PubMed ID: 6842404
[TBL] [Abstract][Full Text] [Related]
31. Clentiazem given at reperfusion improves subendocardial reflow and reduces myocardial infarct size in the dog.
Rousseau G; Provost P; Tran D; Caillé G; Latour JG
J Pharmacol Exp Ther; 1994 Mar; 268(3):1252-60. PubMed ID: 8138938
[TBL] [Abstract][Full Text] [Related]
32. Beneficial effects of the dihydropyridine calcium antagonist, FR 34235, in a chronic coronary occlusion model.
Warltier DC; Zyvoloski MG; Brooks HL; Gross GJ
Eur J Pharmacol; 1982 May; 80(1):149-53. PubMed ID: 7095001
[TBL] [Abstract][Full Text] [Related]
33. Effects of nifedipine on coronary vasculature in canine models of dynamic and fixed coronary stenoses.
Yokoyama M; Sakamoto S; Kusui A; Akita H; Maekawa K; Fukuzaki H
J Pharmacol Exp Ther; 1985 Jun; 233(3):845-52. PubMed ID: 4009492
[TBL] [Abstract][Full Text] [Related]
34. [Underlying mechanism of favorable effect of Ca++-antagonists on conduction delay observed in ischemic myocardium (author's transl)].
Nakaya H
Hokkaido Igaku Zasshi; 1981 May; 56(3):335-45. PubMed ID: 7319455
[TBL] [Abstract][Full Text] [Related]
35. Comparative effects of bepridil, diltiazem, nifedipine and verapamil on haemodynamic parameters and myocardial oxygen consumption in anaesthetized dogs.
Beaughard M; Michelin MT; Tisne-Versailles J; Lamar JC
Arch Int Pharmacodyn Ther; 1986 Dec; 284(2):276-96. PubMed ID: 3493742
[TBL] [Abstract][Full Text] [Related]
36. Blood flow in normal and acutely ischemic myocardium after verapamil, diltiazem and nisoldipine (Bay k 5552), a new dihydropyridine calcium antagonist.
Warltier DC; Meils CM; Gross GJ; Brooks HL
J Pharmacol Exp Ther; 1981 Jul; 218(1):296-302. PubMed ID: 7248040
[No Abstract] [Full Text] [Related]
37. Influence of calcium channel antagonist therapy on the ischemic response to acute coronary occlusion in humans.
Kern MJ
Clin Cardiol; 1989 Jul; 12(7 Suppl 3):III77-85. PubMed ID: 2691144
[TBL] [Abstract][Full Text] [Related]
38. [Effect of the calcium antagonists foridon and nifedipine on systemic hemodynamics and myocardial blood flow in dogs with acute myocardial ischemia].
Glukhovtsev EV
Biull Vsesoiuznogo Kardiol Nauchn Tsentra AMN SSSR; 1988; 11(1):51-4. PubMed ID: 3401343
[TBL] [Abstract][Full Text] [Related]
39. Comparative effects of verapamil, diltiazem, and nifedipine on hemodynamics and left ventricular function during acute myocardial ischemia in dogs.
Urquhart J; Patterson RE; Bacharach SL; Green MV; Speir EH; Aamodt R; Epstein SE
Circulation; 1984 Feb; 69(2):382-90. PubMed ID: 6690104
[TBL] [Abstract][Full Text] [Related]
40. [Selective vasodilatation of the subepicardial coronary vasculature induced by carbochromen (author's transl)].
L'Abbate A; Trivella MG; Camici P; Pelosi G; Levantesi D; Taddei L; Marzilli M
G Ital Cardiol; 1981; 11(5):663-70. PubMed ID: 7286535
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
